Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Detalles Bibliográficos
Autores principales: Hu, Chao, Yu, Mengxia, Ren, Yanling, Li, Kongfei, Maggio, Dominic M., Mei, Chen, Ye, Li, Wei, Juying, Jin, Jie, Zhuang, Zhengping, Tong, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Publisher Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677121/
https://www.ncbi.nlm.nih.gov/pubmed/29116110
http://dx.doi.org/10.1038/s41598-017-14858-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677121/
https://www.ncbi.nlm.nih.gov/pubmed/29116110
http://dx.doi.org/10.1038/s41598-017-14858-z

Ejemplares similares